Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2- seropositive women

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 1, 2012, Pages 77-83

  Stoner, Kevin A ^a   Reighard, Seth D ^b   Miguel, Rodolfo D Vicetti ^b   Landsittel, Douglas ^a   Cosentino, Lisa A ^a   Kant, Jeffrey A ^a   Cherpes, Thomas L ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Bacterial vaginosis; Herpes simplex virus type 2; Metronidazole

Indexed keywords

METRONIDAZOLE;

ADULT; ARTICLE; FEMALE; GRAM STAINING; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; RECURRENCE RISK; VAGINA FLORA; VAGINA SMEAR; VAGINITIS; VIRUS SHEDDING;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; METRONIDAZOLE; RISK FACTORS; VAGINA; VAGINOSIS, BACTERIAL; VIRUS SHEDDING;

EID: 84856300453     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01697.x     Document Type: Article

References (31)

1. Fredricks DN, Fiedler TN, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899-1911. (Pubitemid 41565955)
2. Koumans EH, Sternberg M, Bruce C et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34: 864-869. (Pubitemid 350287499)
3. Minkoff H, Grunebaum AN, Schwarz RH et al. Risk factors for prematurity and premature rupture of membranes: A prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984; 150: 965-972. (Pubitemid 15232024)
4. Taha TE, Hoover DR, Dallabetta GA et al. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. Aids 1998; 12: 1699-1706. (Pubitemid 28418342)
5. Martin HL, Richardson BA, Nyange PM et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180: 1863-1868.
6. Blackwell AL, Fox AR, Phillips I, Barlow D. Anaerobic vaginitis (non-specific vaginitis): Clinical, microbiological, and therapeutic findings. Lancet 1983; 2: 1379-1382. (Pubitemid 14247682)
7. Hagström B, Lindstedt J. Comparison of two different regimens of metronidazole in the treatment of non-specific vaginitis. Scand J Infect Suppl 1983; 40: 95-96. (Pubitemid 14201787)
8. Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: A prospective double-blind clinical trial. South Med J 1992; 85: 1077-1080.
9. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosman J, Mayer H. Efficacy of clindamycin versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993; 82: 405-410. (Pubitemid 23251362)
10. Bradshaw CS, Morton AN, Hocking J et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 1478-1486. (Pubitemid 43794575)
11. Koumans EH, Markowitz LE. Hogan V for the CDC BV Working Group. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: A synthesis of the data. Clin Infect Dis 2002; 35 (Suppl 2): S152-S172. (Pubitemid 35178327)
12. Nagot N, Ouedraogo A, Defer M, Vallo R, Mayaud P, Van de Perre P. Association between bacterial vaginosis and herpes simplex virus type-2 infection: Implications for HIV acquisition studies. Sex Transm Infect 2007; 83: 365-368. (Pubitemid 47242483)
13. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA. A delicate balance: Risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2008; 35: 78-83. (Pubitemid 351619363)
14. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am J Med 1983; 74: 14-22. (Pubitemid 13221599)
15. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 103: 1105-1108.
16. Leyland B, Kennedy MR, Wimberly YH, Levine BJ, Cherpes TL. Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a pointof- care test from Focus Diagnostics. J Clin Virol 2009; 44: 125-128.
17. Centers for Disease Control and Prevention. 2002 Guidelines for treatment of sexually transmitted diseases. MMWR 2002; 51: 1-132.
18. Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL. Genital tract shedding of herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005; 40: 1422-1428. (Pubitemid 40628629)
19. Morison L, Ekpo G,West B et al. Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women. Sex Transm Infect 2005; 81: 242-247. (Pubitemid 40835053)
20. Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010; 86: 297-302.
21. Schwebke JR, Morgan SC, Weiss HL. The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora. Sex Transm Dis 1997; 24: 236-239. (Pubitemid 27155106)
22. Keane FEA, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997; 8: 489-494. (Pubitemid 27308586)
23. Hay PE, Ugwumadu A, Chowns J. Sex, thrush and bacterial vaginosis. Int J STD AIDS 1997; 8: 603-608. (Pubitemid 27389423)
24. Schwebke JR, Richey CM,Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 1999; 180: 1632-1636. (Pubitemid 29506468)
25. Cherpes TL, Meyn LA, Krohn MA, Hillier SL. Risk factors for infection with herpes simplex virus type 2: Role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30: 405-410. (Pubitemid 36605489)
26. Kaul R, Nagelkerke NJ, Kimani J et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Inf Dis 2007; 196: 1692-1697. (Pubitemid 351411969)
27. Hawes SE, Hillier SL, Benedetti J et al. Hydrogen peroxideproducing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-1063. (Pubitemid 26357470)
28. Mijac VD, Dukić SV, Opavski NZ, Dukić MK, Ranin LT. Hydrogen peroxide producing lactobacilli in women with vaginal infections. Eur J Obstet Gynecol Reprod Biol 2006; 129: 69-76. (Pubitemid 44740207)
29. Baeten JM, Hassan WM, Chohan V et al. Prospective study of correlates of vaginal Lactobacillus colonisation among highrisk HIV-1 seronegative women. Sex Transm Dis 2009; 85: 348-353.
30. Schiffer JT, Abu-Radded L, Mark KE et al. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. PNAS 2010; 107: 18973-18978.
31. Priestly CJF, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora? Genitourin Med 1997; 73: 23-28. (Pubitemid 27076083)